Stability challenges in drug discovery

Chemistry and Biodiversity

Volumn 6, Issue 11, 2009, Pages 1875-1886

  Di, Li ^a   Kerns, Edward H ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRODRUG;

BIOASSAY; CONFERENCE PAPER; DEGRADATION; DRUG BIOAVAILABILITY; DRUG QUALITY; DRUG SCREENING; DRUG STABILITY; EXCIPIENT COMPATIBILITY; HIGH THROUGHPUT SCREENING; INTESTINE FLUID; IONIC STRENGTH; MEMBRANE TRANSPORT; PH; PROTEIN BINDING; RISK REDUCTION; STRUCTURE ACTIVITY RELATION; TOXICITY;

BIOLOGICAL AVAILABILITY; BODY FLUIDS; BUFFERS; CHEMISTRY, PHARMACEUTICAL; COMPUTER SIMULATION; DRUG DISCOVERY; DRUG STABILITY; EXCIPIENTS; GASTROINTESTINAL TRACT; PRODRUGS; SOLVENTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 72449154618     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200900061     Document Type: Conference Paper

References (49)

1. E. H. Kerns, L. Di, 'Drug-like Properties: Concepts, Structure Design and Methods: from ADME to Toxicity Optimization', Elsevier, London, 2008.
2. E. H. Kerns, L. Di, in 'ADME-Tox Approaches', Eds. B. Testa, H. van de Waterbeemd, Vol.5 in 'Comprehensive Medicinal Chemistry', 2nd edn., Eds. J. B. Taylor, D. J. Triggle, Elsevier, Oxford, 2007, pp. 489-507.
3. E. H. Kerns, L. Di, in 'Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies', Eds. B. Testa, S. D. Krämer, H. Wunderli-Allespach, G. Folkers, Verlag Helvetica Chimica Acta, Zürich, 2006, pp. 281-306.
4. K. C. Waterman, R. C. Adami, Int. J. Pharm. 2005, 293, 101.
5. K. Nord, J. Karlsen, H. H. Tønnesen, Int. J. Pharm. 1991, 72, 11.
6. 'Chemical Stability of Pharmaceuticals: A Handbook for Pharmacists' Eds. K. A. Connors, G. L. Amidon, V. J. Stella, John Wiley & Sons, New York, 1986.
7. 'Drug Stability: Principles and Practices', 3rd edn., Eds. J. T. Carstensen, C. T. Rhodes, Marcel Dekker, New York, 2000.
8. K. C. Waterman, R. C. Adami, K. M. Alsante, A. S. Antipas, D. R. Arenson, R. Carrier, J. Hong, M. S. Landis, F. Lombardo, J. C. Shah, E. Shalaev, S. W. Smith, H. Wang, Pharm. Dev. Technol. 2002, 7, 113.
9. K. C. Waterman, R. C. Adami, K. M. Alsante, J. Hong, M. S. Landis, F. Lombardo, C. J. Roberts, Pharm. Dev. Technol. 2002, 7, 1.
10. L. Di, E. H. Kerns, H. Chen, S. L. Petusky, J. Biomol. Screening 2006, 11, 40.
11. J. K. Guillory, R. I. Poust, Drugs Pharm. Sci. 2002, 121, 139.
12. P. Yang, F. Macdonald, Drug Dev. Ind. Pharm. 2004, 30, 967.
13. E. A. Gadkariem, F. Belal, M. A. Abounassif, H. A. El-Obeid, K. E. E. Ibrahim, Farmaco 2004, 59, 323.
14. M. S. Islam, M. M. Narurkar, J. Pharm. Pharmacol. 1993, 45, 682.
15. C. E. Pasini, J. M. Indelicato, Pharm. Res. 1992, 9, 250.
16. H. Zhu, K. Meserve, A. Floyd, Drug Dev. Ind. Pharm. 2002, 28, 135.
17. M. F. Powell, J. Pharm. Sci. 1986, 75, 901.
18. V. J. Helm, B. W. Müller, Int. J. Pharm. 1991, 70, 29.
19. J. D. de Vries, J. Winkelhorst, W. J. M. Underberg, R. E. C. Henrar, J. H. Beijnen, Int. J. Pharm. 1993, 100, 181.
20. C. Goolcharran, R. T. Borchardt, J. Pharm. Sci. 1998, 87, 283.
21. Y.-X. Guo, Z.-L. Xiu, D.-J. Zhang, H. Wang, L.-X. Wang, H.-B. Xiao, J. Pharm. Biomed. Anal. 2007, 43, 1249.
22. S. Bhattarai, V. H. Tran, C. C. Duke, J. Pharm. Biomed. Anal. 2007, 45, 648.
23. R. D. Skwierczynski, K. A. Connors, J. Pharm. Sci. 1994, 83, 1690.
24. B. T. Grayson, Pestic. Sci. 1986, 17, 277.
25. N. Ni, T. Sanghvi, S. H. Yalkowsky, Int. J. Pharm. 2002, 249, 257.
26. J. S. Trivedi, W. R. Porter, J. J. Fort, Eur. J. Pharm. Sci. 1996, 4, 109.
27. L. Gu, R. G. Strickley, Int. J. Pharm. 1990, 60, 99.
28. J. Ostergaard, C. Larsen, Molecules 2007, 12, 2380.
29. N. Ohta, T. Yotsuyanagi, K. Ikeda, Chem. Pharm. Bull. 1986, 34, 2585.
30. The United States Pharmacopeia Convention, 'United States Pharmacopeia: the National Formulary' [USP 31-NF 26], Rockville MD, 2009.
31. E. B. Asafu-Adjaye, P. J. Faustino, M. A. Tawakkul, L. W. Anderson, L. X. Yu, H. Kwon, D. A. Volpe, J. Pharm. Biomed. Anal. 2007, 43, 1854.
32. M. Bansal, P. K. Sharma, G. K. Jain, N. Mehrotra, Int. J. Chem. Sci. 2007, 5, 852.
33. S. Jain, R. K. Sharma, S. P. Vyas, J. Pharm. Pharmacol. 2006, 58, 303.
34. E. K. Wasan, K. Bartlett, P. Gershkovich, O. Sivak, B. Banno, Z. Wong, J. Gagnon, B. Gates, C. G. Leon, K. M. Wasan, Int. J. Pharm. 2009, 372, 76.
35. L. P. Massicotte, W. E. Baille, M. A. Mateescu, Int. J. Pharm. 2008, 356, 212.
36. L. Di, H. E. Kerns. Curr. Drug Metab. 2008, 9, 860.
37. G. M. Rishton, Drug Discovery Today 1997, 2, 382.
38. G. M. Rishton, Drug Discovery Today 2003, 8, 86.
39. D. E. Epps, B. M. Taylor, Anal. Biochem. 2001, 295, 101.
40. J. R. Huth, R. Mendoza, E. T. Olejniczak, R. W. Johnson, D. A. Cothron, Y. Liu, C. G. Lerner, J. Chen, P. J. Hajduk, J. Am. Chem. Soc. 2005, 127, 217.
41. V. H. Thomas, M. Naath, Int. J. Pharm. 2008, 359, 150.
42. T. Huang, M. E. Garceau, P. Gao, J. Pharm. Biomed. Anal. 2003, 31, 1203.
43. L. Chafetz, W.-H. Hong, D. C. Tsilifonis, A. K. Taylor, J. Philip, J. Pharm. Sci. 1984, 73, 1186.
44. M. N. Nassar, V. N. Nesarikar, R. Lozano, W. L. Parker, Y. Huang, V. Palaniswamy, W. Xu, N. Khaselev, Pharm. Dev. Technol. 2004, 9, 189.
45. D. Desai, V. Rao, H. Guo, D. Li, M. Bolgar, Int. J. Pharm. 2007, 342, 87.
46. Y. Hirakura, M. Nakamura, T. Wakasawa, K. Ban, S. Yokota, S. Kitamura, Int. J. Pharm. 2006, 325, 26.
47. P. Ettmayer, G. L. Amidon, B. Clement, B. Testa, J. Med. Chem. 2004, 47, 2393.
48. V. J. Stella, K. W. Nti-Addae, Adv. Drug Delivery Rev. 2007, 59, 677.
49. B. Testa, J. M. Mayer, ' Hydrolysis in Drug and Prodrug Metabolism: Chemistry, Biochemistry, and Enzymology', Verlag Helvetica Chimica Acta, Zurich, and Wiley VCH, Weinheim, 2003.